(19)
(11) EP 3 743 413 A1

(12)

(43) Date of publication:
02.12.2020 Bulletin 2020/49

(21) Application number: 19704152.8

(22) Date of filing: 22.01.2019
(51) International Patent Classification (IPC): 
C07D 313/08(2006.01)
C07D 333/64(2006.01)
C07D 409/12(2006.01)
C07D 209/12(2006.01)
A61P 35/00(2006.01)
A61K 31/404(2006.01)
C07C 215/48(2006.01)
C07D 487/04(2006.01)
C07D 209/30(2006.01)
(86) International application number:
PCT/US2019/014581
(87) International publication number:
WO 2019/144132 (25.07.2019 Gazette 2019/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 22.01.2018 US 201862620441 P

(71) Applicant: RADIUS PHARMACEUTICALS, INC.
Waltham, MA 02451 (US)

(72) Inventor:
  • MILLER, Chris
    San Mateo, CA 94402 (US)

(74) Representative: Potter Clarkson 
The Belgrave Centre Talbot Street
Nottingham NG1 5GG
Nottingham NG1 5GG (GB)

   


(54) ESTROGEN RECEPTOR-MODULATING COMPOUNDS